UBS O'Connor’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-316,204
| Closed | -$3.27M | – | 586 |
|
|
2023
Q2 | $3.27M | Sell |
316,204
-3,899
| -1% | -$40.3K | 0.07% | 177 |
|
|
2023
Q1 | $3.24M | Buy |
+320,103
| New | +$3.24M | 0.08% | 196 |
|
|
2022
Q4 | – | Sell |
-320,103
| Closed | -$3.12M | – | 375 |
|
|
2022
Q3 | $3.12M | Sell |
320,103
-32,585
| -9% | -$318K | 0.04% | 428 |
|
|
2022
Q2 | $3.43M | Buy |
+352,688
| New | +$3.43M | 0.04% | 433 |
|
|
2022
Q1 | – | Sell |
-352,688
| Closed | -$3.41M | – | 249 |
|
|
2021
Q4 | $3.41M | Buy |
352,688
+1,709
| +0.5% | +$16.5K | 0.03% | 386 |
|
|
2021
Q3 | $3.4M | Buy |
+350,979
| New | +$3.4M | 0.03% | 402 |
|